{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:44:46Z","timestamp":1792813486733,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","ejradiology.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejrad.2025.111982","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:54:38Z","timestamp":1738713278000},"page":"111982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["MRI-based risk stratification for clinically significant prostate cancer detection at biopsy: The value of zonal-specific PSA density and PSHS"],"prefix":"10.1016","volume":"184","author":[{"given":"Antonia M.","family":"Pausch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soleen","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Notter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Benke-Bruderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"von Felten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels J.","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Eberli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"H\u00f6tker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2025.111982_b0005","unstructured":"P. Cornford, D. Tilki, R.C. Van Den Bergh, EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024., in: EAU Guidelines Office, Arnhem, The Netherlands, n.d. https:\/\/uroweb.org\/guidelines."},{"key":"10.1016\/j.ejrad.2025.111982_b0010","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"PRECISION study group collaborators, MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2025.111982_b0015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","author":"Ahmed","year":"2017","journal-title":"The Lancet 389"},{"key":"10.1016\/j.ejrad.2025.111982_b0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0219","article-title":"Assessment of the diagnostic accuracy of biparametric magnetic resonance imaging for prostate cancer in biopsy-naive men: the biparametric MRI for detection of prostate cancer (BIDOC) Study","volume":"1","author":"Boesen","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ejrad.2025.111982_b0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bju.14049","article-title":"Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-na\u00efve men with suspicion of prostate cancer","volume":"122","author":"Hansen","year":"2018","journal-title":"BJU Int."},{"key":"10.1016\/j.ejrad.2025.111982_b0030","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012663.pub2","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejrad.2025.111982_b0035","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1148\/radiol.2019182946","article-title":"PI-RADS steering committee: the PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway","volume":"292","author":"Padhani","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.111982_b0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bju.15277","article-title":"Risk\u2010adapted biopsy decision based on prostate magnetic resonance imaging and prostate\u2010specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation","volume":"127","author":"Schoots","year":"2021","journal-title":"BJU Int."},{"key":"10.1016\/j.ejrad.2025.111982_b0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1148\/radiol.2021204112","article-title":"Avoiding unnecessary biopsy: MRI-based risk models versus a PI-RADS and PSA density strategy for clinically significant prostate cancer","volume":"300","author":"Deniffel","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.111982_b0050","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s00330-021-08407-6","article-title":"Risk-based MRI-directed diagnostic pathway outperforms non-risk-based pathways in suspected prostate cancer biopsy-na\u00efve men: a large cohort validation study","volume":"32","author":"Bittencourt","year":"2022","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2025.111982_b0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euo.2018.09.001","article-title":"Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7\u201310 Prostate cancer in biopsy-na\u00efve men","volume":"2","author":"Boesen","year":"2019","journal-title":"European Urology Oncology"},{"key":"10.1016\/j.ejrad.2025.111982_b0060","doi-asserted-by":"crossref","unstructured":"F. Pellegrino, A.L. Tin, A. Martini, E.A. Vertosick, S.P. Porwal, A. Stabile, G. Gandaglia, J.A. Eastham, A. Briganti, F. Montorsi, A.J. Vickers, Prostate-specific Antigen Density Cutoff of 0.15 ng\/ml\/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past?, Eur Urol Focus 9 (2023) 291\u2013297. doi: 10.1016\/j.euf.2022.10.002.","DOI":"10.1016\/j.euf.2022.10.002"},{"key":"10.1016\/j.ejrad.2025.111982_b0065","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.euf.2023.01.020","article-title":"Prediction of significant prostate cancer in equivocal magnetic resonance imaging lesions: a high-volume international multicenter study","volume":"9","author":"Sigle","year":"2023","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.ejrad.2025.111982_b0070","unstructured":"D.G. Bostwick, Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer, Am. J. Clin. Pathol. 102 (1994) S31-37."},{"key":"10.1016\/j.ejrad.2025.111982_b0075","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s11255-006-9125-2","article-title":"The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis","volume":"39","author":"Ozden","year":"2007","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ejrad.2025.111982_b0080","doi-asserted-by":"crossref","unstructured":"B.H. G\u00fcm\u00fc\u015f, N. Ne\u015fe, M.I. G\u00fcnd\u00fcz, A.R. Kandilo\u011flu, Y. Ceylan, C. B\u00fcy\u00fcksu, Does asymptomatic inflammation increase PSA? A histopathological study comparing benign and malignant tissue biopsy specimens, Int Urol Nephrol 36 (2004) 549\u2013553. doi: 10.1007\/s11255-004-0845-x.","DOI":"10.1007\/s11255-004-0845-x"},{"key":"10.1016\/j.ejrad.2025.111982_b0085","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.urology.2004.08.060","article-title":"Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study","volume":"64","author":"Simardi","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.ejrad.2025.111982_b0090","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2214\/AJR.18.20295","article-title":"The influence of background signal intensity changes on cancer detection in prostate MRI","volume":"212","author":"H\u00f6tker","year":"2019","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2025.111982_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110733","article-title":"Multi-reader evaluation of different image quality scoring systems in prostate MRI","volume":"161","author":"H\u00f6tker","year":"2023","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2025.111982_b0100","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2214\/AJR.20.22843","article-title":"Prostatitis, the great mimicker of prostate cancer: can we differentiate them quantitatively with multiparametric MRI?","volume":"215","author":"Uysal","year":"2020","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2025.111982_b0105","doi-asserted-by":"crossref","unstructured":"R.B. Nadler, P.A. Humphrey, D.S. Smith, W.J. Catalona, T.L.* Ratliff, Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen Levels, The Journal of Urology 154 (1995) 407\u2013413. doi: 10.1016\/S0022-5347(01)67064-2.","DOI":"10.1016\/S0022-5347(01)67064-2"},{"key":"10.1016\/j.ejrad.2025.111982_b0110","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1007\/s00330-024-10700-z","article-title":"Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies","volume":"34","author":"Hamm","year":"2024","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2025.111982_b0115","doi-asserted-by":"crossref","unstructured":"B. Turkbey, A.B. Rosenkrantz, M.A. Haider, A.R. Padhani, G. Villeirs, K.J. Macura, C.M. Tempany, P.L. Choyke, F. Cornud, D.J. Margolis, H.C. Thoeny, S. Verma, J. Barentsz, J.C. Weinreb, Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2, European Urology 76 (2019) 340\u2013351. doi: 10.1016\/j.eururo.2019.02.033.","DOI":"10.1016\/j.eururo.2019.02.033"},{"key":"10.1016\/j.ejrad.2025.111982_b0120","unstructured":"R Core Team, R: A Language and Environment for Statistical Computing, (2023). https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.ejrad.2025.111982_b0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejrad.2025.111982_b0130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1198\/106186006X133933","article-title":"Unbiased recursive partitioning: a conditional inference framework","volume":"15","author":"Hothorn","year":"2006","journal-title":"J. Comput. Graph. Stat."},{"key":"10.1016\/j.ejrad.2025.111982_b0135","first-page":"3905","article-title":"partykit: A modular toolkit for recursive partytioning in R","author":"Hothorn","year":"2015","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.ejrad.2025.111982_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.111151","article-title":"Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral zone in men without prostate cancer","volume":"169","author":"Al-Monajjed","year":"2023","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2025.111982_b0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.euf.2019.11.012","article-title":"The Value of prostate-specific antigen density for prostate imaging-reporting and data system 3 lesions on multiparametric magnetic resonance imaging: a strategy to avoid unnecessary prostate biopsies","volume":"7","author":"G\u00f6rtz","year":"2021","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.ejrad.2025.111982_b0150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1590\/s1677-5538.ibju.2017.0506","article-title":"Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ng\/mL","volume":"44","author":"Castro","year":"2018","journal-title":"Int. Braz. J. Urol."},{"key":"10.1016\/j.ejrad.2025.111982_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108660","article-title":"Comparison of PSA-density of the transition zone and whole gland for risk stratification of men with suspected prostate cancer: a retrospective MRI-cohort study","volume":"120","author":"Schneider","year":"2019","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2025.111982_b0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4103\/aja.aja_72_20","article-title":"Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml: \u20131","volume":"23","author":"Wang","year":"2021","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.ejrad.2025.111982_b0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/JU.0000000000000757","article-title":"Predictive factors of missed clinically significant prostate cancers in men with negative magnetic resonance imaging: a systematic review and meta-analysis","volume":"204","author":"Pagniez","year":"2020","journal-title":"J. Urol."},{"key":"10.1016\/j.ejrad.2025.111982_b0170","article-title":"Risk factors for prostate cancer in men with false-negative mpMRI: a retrospective single center cohort study of image quality scores and clinical parameters","volume":"170","author":"Pausch","year":"2023","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2025.111982_b0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.euros.2022.01.006","article-title":"There is no longer a role for systematic biopsies in prostate cancer diagnosis","volume":"38","author":"Kasivisvanathan","year":"2022","journal-title":"Eur. Urol. Open Sci."},{"key":"10.1016\/j.ejrad.2025.111982_b0180","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000001200","article-title":"Interreader agreement with prostate imaging reporting and data system version 2 for prostate cancer detection: a systematic review and meta-analysis","author":"Park","year":"2020","journal-title":"J. Urol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T14:11:22Z","timestamp":1745676682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X25000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":36,"alternative-id":["S0720048X25000683"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.111982","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI-based risk stratification for clinically significant prostate cancer detection at biopsy: The value of zonal-specific PSA density and PSHS","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.111982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111982"}}